Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
12/2003
12/11/2003WO2003101202A1 Intraperitoneal delivery of genetically engineered mesenchymal stem cells
12/11/2003WO2003101184A2 Carotenoid synthesis
12/11/2003WO2003084334A3 Method and composition for the prevention or retarding of staling
12/11/2003WO2003078597A9 Tissue engineering
12/11/2003WO2003074670A3 Lis promoter for expression of transgenes in floral tissues
12/11/2003WO2003073068A3 Population based assessments and means to rank the relative immunogenicity of proteins
12/11/2003WO2003071861A3 Vanillin biosynthetic pathway enzyme from vanilla planifolia
12/11/2003WO2003057138A3 Expression of lysosomal hydrolase in cells expressing pro-n-acetylglucosamine-1-phosphodiester alpha-n-acetyl glucosimanidase
12/11/2003WO2003050274A3 Process for harvesting crystalline particles from fermentation broth
12/11/2003WO2003045986A3 Purified polypeptides involved in general metabolism as possible drug targets
12/11/2003WO2003038037A3 Glycogen synthase kinase function in endothelial cells
12/11/2003WO2003038035A3 T. reesei phytase enzymes, polynucleides encoding the enzymes, vectors and host cells thereof, and methods of using
12/11/2003WO2003035827A3 Plasticized hydrophilic glasses for improved stabilization of biological agents
12/11/2003WO2003033672A3 Nr3b nmda receptor subunit compositions and related methods
12/11/2003WO2003029486A3 Single nucleotide polymorphisms predicting cardiovascular disease
12/11/2003WO2003029422A3 Noonan syndrome gene
12/11/2003WO2003029407A3 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof
12/11/2003WO2003027292A3 Regulation of human fatty acid-coa ligase-like enzyme
12/11/2003WO2003025132A3 Dna polymerases and mutants thereof
12/11/2003WO2003014370A3 Process for the fermentative preparation of l-amino acids using coryneform bacteria
12/11/2003WO2003010311A3 Process for preparing variant polynucleotides
12/11/2003WO2003006656A3 Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses
12/11/2003WO2003002730A3 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method
12/11/2003WO2002101056A3 Conjugated linoleic acid isomerase and a process for the production of conjugated linoleic acid
12/11/2003WO2002088387A3 Amplification process
12/11/2003WO2002077166A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
12/11/2003WO2002063975A3 Feed additive compositions and methods
12/11/2003WO2002061108A3 Microorganisms and processes for enhanced production of pantothenate
12/11/2003WO2002040657A3 47169 and 33935, novel glycosyl transferases and uses therefor
12/11/2003US20030229923 Nucleic acid molecules encoding alternansucrase
12/11/2003US20030229922 Comprises nucleotide sequences coding enzymatic polypeptide that modifies plant polysaccharides of cell wall for preparing cellulose acetate, synthetic textiles, biodegradable plastics and digestible medicine capsules
12/11/2003US20030229921 Microbial beta-glucuronidase genes, gene products and uses thereof
12/11/2003US20030229917 Phytic acid biosyntetic enzymes
12/11/2003US20030229916 Phosphoribosylaminoimidazole carboxylase
12/11/2003US20030229914 Sterol metabolism enzymes
12/11/2003US20030229453 Crystals and structures of PAK4KD kinase PAK4KD
12/11/2003US20030229209 Comprises mitogen-activated protein (MAP) kinase polypeptide for treating muscular, diabetic and nervous system disorders
12/11/2003US20030229203 Chemokine variants and methods of use
12/11/2003US20030229068 Controlling apoptosis, cell proliferation; strokes; anticancer agents; central nervous system disorders
12/11/2003US20030229043 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
12/11/2003US20030229036 Administering Dna vector; genetic engineering; gene replacement therapy
12/11/2003US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies
12/11/2003US20030229018 Dimeric TF antagonist
12/11/2003US20030229016 Genetic engineering; binding to antibody
12/11/2003US20030229010 Antidiabetic agents; water in oil microemulsion; immobilization
12/11/2003US20030229006 Amphiphilic oligomers
12/11/2003US20030228995 Multiply-substituted protease variants with altered net charge for use in detergents
12/11/2003US20030228678 Alleles of the aceA gene from coryneform bacteria
12/11/2003US20030228676 Comprises nucleotide sequences coding proteolytic enzyme asociated with aggrecan degradation for treating degenerative joint diseases
12/11/2003US20030228675 Comprises nucleotide sequences coding phosphoinositide 3-kinase related kinases (PIKKS) for diagnosing and treating cell proliferative and apoptotic disorders
12/11/2003US20030228674 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
12/11/2003US20030228673 Novel glucose 6-oxidases
12/11/2003US20030228672 Comprises nucleotide sequences coding oxidoreductases for transformation and fermentive production of 2-keto-L-gulonic acid
12/11/2003US20030228671 Fermenting lactic acid in kluyveromyces for use in cosmetics, pharmaceuticals, plastics and food production
12/11/2003US20030228670 Synthetic enzymes for the production of coniferyl alcohol, coniferylaldehyde, ferulic acid, vanillin and vanillic acid and their use
12/11/2003US20030228669 Contain the genes required for polyhydroxyalkanoate formation integrated on the chromosome
12/11/2003US20030228668 Fatty acyl-CoA: fatty alcohol acyltransferases
12/11/2003US20030228664 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2003US20030228661 Genes encoding sulfate assimilation proteins
12/11/2003US20030228656 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2003US20030228655 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2003US20030228649 Polypeptides for identifying fungicidally active compounds
12/11/2003US20030228648 Mammalian catalase-dependent oxidation processes and methods for stimulating oxidative activities
12/11/2003US20030228646 Fluorescence-based assays for determining the phosphorylating or the dephosphorylating activity of an enzyme acting on a substrate molecule
12/11/2003US20030228621 Methods for screening candidate ligands for binding to a NAD binding receptor, which include contacting a receptor with a candidate ligand and a composition of the invention followed by evaluation of receptor binding
12/11/2003US20030228616 DNA polymerase mutants with reverse transcriptase activity
12/11/2003US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof
12/11/2003US20030228602 Using microarrays to prepare preferential nucleotide sequences for use as tools in genome analysis
12/11/2003US20030228595 Peptides and proteins that effect protein phosphorylation; useful in the development of human therapeutics and diagnostic formulations
12/11/2003US20030228593 Ribozymes with broad tRNA aminoacylation activity
12/11/2003US20030228589 Incubating the composition containing a target nucleic acid template, a primer, an extendable nucleotide, and thermus thermophilus GK24 and thermus oshimai(G43D, F665Y) under appropriate conditions to generate primer extension product
12/11/2003US20030228584 Novel nucleic acids and polypeptides
12/11/2003US20030228576 Nucleotide sequence coding for a cleaving enzyme; can use in conjuction with substrate to produce toxins which impair abnormal cell growth; antitumor agents
12/11/2003US20030228568 Inducible phosphofructokinase and the warburg effect
12/11/2003US20030228330 Prevent reproduction of poxvirus; genetic engineering; transcription control
12/11/2003US20030228298 Antiproliferative agents
12/11/2003CA2736926A1 Tumour associated peptides that bind to mhc molecules
12/11/2003CA2493863A1 Arrays identifying genomic and proteomic biomarkers for cystic fibrosis
12/11/2003CA2488568A1 Methods of diagnosing and treating diabetes and insulin resistance
12/11/2003CA2488547A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/11/2003CA2488539A1 Novel proteins and nucleic acids encoding same
12/11/2003CA2488196A1 Methods and materials for the production of lactic acid in yeast
12/11/2003CA2488048A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
12/11/2003CA2487513A1 Improved receptor detection
12/11/2003CA2487296A1 Methods and materials for the production of d-lactic acid in yeast
12/11/2003CA2487291A1 Human prolactin antagonist-angiogenesis inhibitor fusion proteins
12/11/2003CA2487024A1 Control sequences of the human corin gene
12/11/2003CA2486530A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
12/11/2003CA2485513A1 Modified phytases
12/11/2003CA2485203A1 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants
12/11/2003CA2483872A1 Proteins and methods useful for assessing risk of cardiovascular disease
12/10/2003EP1369492A1 Detection of staphylococcus spp
12/10/2003EP1369487A2 Recombinant vectors derived from adenovirus for use in gene therapy
12/10/2003EP1369485A1 Glucose dehydrogenase
12/10/2003EP1369484A1 Plant synthesizing copolyester from monomer derived from short-chain fatty acid and process for producing polyester
12/10/2003EP1368496A1 Method for alteration detection
12/10/2003EP1368482A2 Nitrile hydratase and a method for producing amides
12/10/2003EP1368481A2 Characterization of the i-spoml endonuclease from fission yeast
12/10/2003EP1368480A2 Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene
12/10/2003EP1368479A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof